Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for the Pharmaceutical Industry 2024
Language:
Japanese
Product Code No:
C66104700
Issued In:
2024/06
#of Pages:
321
Publication Cycle:
Format:
PDF
Geographic Coverage:
,
Japan
,
Industry:
Jump to the Japanese Page:
Coverage: (Product/service)
Bulk Drug Substances (Active Pharmaceutical Ingredients) and Drug Intermediates
Research Target:
Bulk Drug Substances (Active Pharmaceutical Ingredients) and intermediates for pharmaceutical products; contract manufacturers of APIs and intermediates (CMOs), pharmaceutical companies
Research Content:
I Market Trend Analysis of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates for Pharmaceuticals
1. Transition of Market Size of Bulk Drug Substances and Intermediates （FY2020-FY2023）
2. Trends of Bulk Drug Substances and Intermediates Manufacturers
3. Problems and Challenges for Companies manufacturing Bulk Drug Substances and Intermediates
4. Market Outlook of Bulk Drug Substances and Intermediates
5. Estimated Market Size of Bulk Drug Substances and Intermediates (FY2024- FY2028)
II Analysis of Market Strategies Taken by Leading Manufacturers of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates for Pharmaceuticals
1. Business Outline
2. Recent Requests from Pharmaceutical Companies
3. R&D Trends
4. Production and Quality Management Trends
5. Sales Trends
6. Future Market Strategies
7. Promising Business Areas, Demand Forecasts
III Market Strategies of Noteworthy Manufacturing Companies of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermidiates [Company Profiles]
IV Profiles of Leading Manufacturers of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates [Brief Profiles]